[Pharmacological cardioversion of atrial fibrillation]
- PMID: 15668825
- DOI: 10.1007/s00392-005-0166-9
[Pharmacological cardioversion of atrial fibrillation]
Abstract
Atrial fibrillation is a very common rhythm disorder that can be therapeutically reverted into sinus rhythm by means of pharmacological or electrical cardioversion. This article reviews options for drug therapy and tries to elucidate the mechanisms of AF termination by antiarrhythmics. We will explain the clinical basis of different therapeutic approaches and review the efficacy of selected substances according to recent clinical studies. Finally, we will focus on some important aspects of anticoagulation in the setting of pharmacological cardioversion.
Similar articles
-
Pharmacological cardioversion of atrial fibrillation: current management and treatment options.Drugs. 2004;64(24):2741-62. doi: 10.2165/00003495-200464240-00003. Drugs. 2004. PMID: 15563247 Review.
-
Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.Intern Emerg Med. 2017 Sep;12(6):853-859. doi: 10.1007/s11739-016-1497-4. Epub 2016 Jul 6. Intern Emerg Med. 2017. PMID: 27384766
-
Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone.Am J Cardiol. 2000 Dec 15;86(12):1384-5, A5. doi: 10.1016/s0002-9149(00)01250-9. Am J Cardiol. 2000. PMID: 11113420
-
Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.Eur Heart J. 2000 Jan;21(1):66-73. doi: 10.1053/euhj.1999.1734. Eur Heart J. 2000. PMID: 10610746 Clinical Trial.
-
[Pharmacological therapy of atrial fibrillation and atrial flutter].Herz. 2002 Jun;27(4):329-44. doi: 10.1007/s00059-002-2390-7. Herz. 2002. PMID: 12187863 Review. German.
Cited by
-
Pharmacological and ablative hybrid therapy of atrial fibrillation. Long-term effect on quality of life and arrhythmia-related symptoms.Z Kardiol. 2005 Sep;94(9):564-9. doi: 10.1007/s00392-005-0263-9. Z Kardiol. 2005. PMID: 16142515 Clinical Trial.
-
Simultaneous angiographic imaging of ipsilateral pulmonary veins for catheter ablation of atrial fibrillation.Clin Res Cardiol. 2006 Nov;95(11):591-9. doi: 10.1007/s00392-006-0433-4. Epub 2006 Sep 8. Clin Res Cardiol. 2006. PMID: 16941084
-
Effect of transcoronary ablation of septal hypertrophy on clinical outcome in hypertrophic obstructive cardiomyopathy associated with atrial fibrillation.Clin Res Cardiol. 2006 May;95(5):254-60. doi: 10.1007/s00392-006-0372-0. Epub 2006 Mar 21. Clin Res Cardiol. 2006. PMID: 16598396 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical